Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025

Methods for treating late-stage small cell lung cancer by administering a human anti-PD-L1 antibody, an etoposide and a platinum-based therapeutic

US Patent 12012453 · Granted Jun 18, 2024

Estimated economic value: $238,205,000

Assignee

Inventors

View full patent text on Google Patents →